Vendor, Radnor, PA
Idorsia Pharmaceuticals US Inc.
UEI YWKKJS5RYQJ9, CAGE 99J34
3 awards and $0 obligated between May 7, 2024 and April 17, 2026, 100% under full and open competition, against 333.7 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79723D0017May 7, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Update the Terms of the CRF Payment Remittal and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79725A0005February 18, 2025, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for TryvioNAICS 325412, PSC 6505 | $0 |
| 36F79722D0224August 1, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Point of Contact UpdatedNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 15 across 3 awards